These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 7564347
1. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man. McIntyre M, MacFadyen RJ, Meredith PA, Menard J, Brunner HR, Insuasty J, Reid JL. J Cardiovasc Pharmacol; 1995 Jun; 25(6):994-1000. PubMed ID: 7564347 [Abstract] [Full Text] [Related]
2. Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I. Inglessis N, Nussberger J, Hagmann M, Hiesse-Provost O, Insuasty J, Reid J, Ménard J, Brunner HR. J Cardiovasc Pharmacol; 1995 Jun; 25(6):986-93. PubMed ID: 7564346 [Abstract] [Full Text] [Related]
3. Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men. McIntyre M, MacFadyen RJ, Meredith PA, Brouard R, Reid JL. J Cardiovasc Pharmacol; 1996 Jul; 28(1):101-6. PubMed ID: 8797143 [Abstract] [Full Text] [Related]
7. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Azizi M, Guyene TT, Chatellier G, Wargon M, Ménard J. Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450 [Abstract] [Full Text] [Related]
9. SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers. Hagmann M, Nussberger J, Naudin RB, Burns TS, Karim A, Waeber B, Brunner HR. J Cardiovasc Pharmacol; 1997 Apr; 29(4):444-50. PubMed ID: 9156352 [Abstract] [Full Text] [Related]
13. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G. Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751 [Abstract] [Full Text] [Related]
15. Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers. Doig JK, MacFadyen RJ, Sweet CS, Reid JL. J Cardiovasc Pharmacol; 1995 Apr; 25(4):511-7. PubMed ID: 7596116 [Abstract] [Full Text] [Related]
17. Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men. Ribstein J, Picard A, Armagnac C, Sissmann J, Mimran A. J Cardiovasc Pharmacol; 2001 Apr; 37(4):449-60. PubMed ID: 11300658 [Abstract] [Full Text] [Related]
18. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man. Yee KM, Struthers AD. Br J Clin Pharmacol; 1998 Dec; 46(6):583-8. PubMed ID: 9862248 [Abstract] [Full Text] [Related]
20. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition. Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson JI. Am J Med; 1984 Aug 20; 77(2A):52-60. PubMed ID: 6089557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]